Details checkedStrong evidenceCheckedcompany

Sennheiser Conversation Clear Plus

Also known as: Conversation Clear Plus, ConC 400, Sennheiser speech-enhancement earbuds

Sennheiser Hearing

Primary source

Company

Sennheiser Hearing

Program Type

Device

Modality

Hearing Aid/Software

Stage

Marketed

Status

Marketed

Target Gene

—

Route / Mode

True-wireless speech-enhancement earbuds with companion app

Confidence

84%

Status Confidence

Status confirmed

Evidence Strength

Strong evidence

Last Reviewed

2026-06-10

Geography

United States, Europe, Global

Population

adult, age-related, speech-in-noise, consumer-audio

Trial IDs

Mechanism

Consumer true-wireless earbuds with advanced speech enhancement, active noise cancellation, and app-based personalization for clearer conversations in noisy environments.

Indications

Hearing Loss Sensorineural Hearing Loss Age-Related Hearing Loss

Notes

Adds a consumer speech-enhancement hearable distinct from full OTC hearing aids; useful for separating AI/audio accessibility products from prescription and OTC hearing-aid hardware.

Evidence & Sources

2 structured sources

company

Supports: canonicalName, aliases, company, programType, modality, mechanism, status, route

Open

company

Supports: notes, keyEvents

Open

Key Events

2023-01-05

Sennheiser announced Conversation Clear Plus speech-enhanced consumer wearables

Related Programs